Pharmaids Pharmaceuticals Ltd (524572) Stock Price & News

524572:BOM

Pharmaids Pharmaceuticals Ltd

₹30.59

+0.46%

(+0.14) 1D

Oct 16, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 524572...

Open

₹30.35

High

₹32.50

Low

₹29.80

Mkt. cap

1.06B

Avg. vol.

3.45K

Volume

3.76K

52-wk high

₹53.90

52-wk low

₹25.60

EPS

-₹1.29

Shares outstanding

3.41M

No. of employees

127

Open

₹30.35

High

₹32.50

Low

₹29.80

Mkt. cap

1.06B

Avg. vol.

3.45K

Volume

3.76K

52-wk high

₹53.90

52-wk low

₹25.60

EPS

-₹1.29

Shares outstanding

3.41M

No. of employees

127

News stories

From web sources and news partners

Benzinga

33 minutes ago

Dow Jones, Nasdaq 100, S&P 500 Outlook: Top Catalysts to Move US Stocks This Week

Yahoo Finance UK

4 hours ago

Yardeni Lowers S&P 500 Target to 7,900 Despite Maintaining 2027 Earnings Forecast

MarketWatch

4 hours ago

These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth

Moomoo

1 day ago

There Is a Silent Market Rotation Inside the S&P 500 That's Warning of More Weakness Ahead

About Pharmaids Pharmaceuticals Ltd

CEO-

Employees127

Founded1989

Headquarters-

SectorPharmaceutical industry

Websitepharmaids.com

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	86.05M	54.30M	71.84M	41.21M
Cost of goods sold	75.50M	23.48M	45.15M	16.17M
Cost of revenue	75.50M	23.48M	45.15M	16.17M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	31.81M	32.83M	76.78M	24.66M
Operating expense	68.44M	60.62M	34.80M	37.34M
Total operating expenses	143.95M	84.10M	79.94M	53.52M
Operating income	-57.90M	-29.80M	-8.11M	-12.30M
Other non operating income	2.22M	760.00K	-2.73M	483.00K
EBT including unusual items	-36.57M	-40.22M	-14.56M	24.14M
EBT excluding unusual items	-66.45M	-36.22M	-12.62M	-17.86M
Income tax expense	-11.29M	-13.76M	-3.71M	5.43M
Effective tax rate	30.87%	34.20%	25.48%	22.49%
Other operating expenses	31.96M	23.04M	-46.75M	7.83M
Net income	-24.80M	-24.79M	-18.09M	22.05M
Net profit margin	-28.83%	-45.65%	-25.18%	53.51%
Earnings per share	-	-	-	-
Interest and investment income	-	-	1.54M	-
Interest expense	-10.77M	-7.18M	-4.36M	-6.04M
Net interest expenses	-10.77M	-7.18M	-2.82M	-6.04M
Depreciation and amortization charges	4.68M	4.76M	4.77M	4.86M
EBITDA	-52.53M	-25.07M	-4.50M	-7.23M
Gain or loss from assets sale	-	-	-	-

Ask anything